Urogen Pharma Inc (URGN)
UroGen Pharma Expands Commercial Portfolio with Launch ofZUSDURI™ and Reports Second Quarter 2025 Financial Results
UroGen Pharma Expands Commercial Portfolio with Launch ofZUSDURI™ and Reports Second Quarter 2025 Financial Results
There are no comments here yet...